Skip to content
← Full study record

NCT03693742 · OUTCOME

Tumour Maximal Standardized Uptake Values Corrected for Lean Body Mass (SULmax) for 18F-DCFPyL

MSG Use With 18F-DCFPyL PET/CT Imaging · Source last updated 2023-02-21

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

Measure
MEDIAN
Unit
SULmax
Interval / dispersion
Full Range
Time frame
scan with MSG and 3-7 days later, scan with Placebo (or vice versa)

What was measured

Comparison of MSG and placebo 18F-DCFPyL tumour accumulation measured by the maximal standardized uptake values corrected for lean body mass (SULmax). For determination of tumour uptake, all malignant lesions, the SULmax were measured using the PET Edge tool running on MIM. All regions of interest were created in one dataset by a blinded observer, and then saved and compared to the identical location in the second dataset for matched comparisons of activity. The median SULmax in the malignant lesions will be used for this analysis.

Analysis population: All participants who received at least one dose of each intervention and completed all study visits were included in the efficacy analysis.

Groups in this outcome

18F-DCFPyL PET/CT Scan With MSG Drink

Participants who received MSG dissolved in juice, in a fasting state, prior to the administration of 18F-DCFPyL, in either the first or second PET/CT scan.

18F-DCFPyL PET/CT Scan With Placebo Drink

Participants who received the Placebo juice, in a fasting state, prior to the administration of 18F-DCFPyL, in either the first or second PET/CT scan.

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Analysis denominator · Participants

GroupSource count
18F-DCFPyL PET/CT Scan With MSG Drink10
18F-DCFPyL PET/CT Scan With Placebo Drink10

Analysis denominator · malignant lesions

GroupSource count
18F-DCFPyL PET/CT Scan With MSG Drink140
18F-DCFPyL PET/CT Scan With Placebo Drink142

Reported measurements

Source class 1
Values in SULmax · Interval/dispersion: Full Range
GroupValueSpreadLowerUpperComment
18F-DCFPyL PET/CT Scan With MSG Drink2.8Not reported0.723.4Not reported
18F-DCFPyL PET/CT Scan With Placebo Drink4.4Not reported1.130.3Not reported
Complete source fields
classes
  1. categories
    1. measurements
      1. group Id
        OG000
        lower Limit
        0.7
        upper Limit
        23.4
        value
        2.8
      2. group Id
        OG001
        lower Limit
        1.1
        upper Limit
        30.3
        value
        4.4
denom Units Selected
malignant lesions
denoms
  1. counts
    1. group Id
      OG000
      value
      10
    2. group Id
      OG001
      value
      10
    units
    Participants
  2. counts
    1. group Id
      OG000
      value
      140
    2. group Id
      OG001
      value
      142
    units
    malignant lesions
description
Comparison of MSG and placebo 18F-DCFPyL tumour accumulation measured by the maximal standardized uptake values corrected for lean body mass (SULmax). For determination of tumour uptake, all malignant lesions, the SULmax were measured using the PET Edge tool running on MIM. All regions of interest were created in one dataset by a blinded observer, and then saved and compared to the identical location in the second dataset for matched comparisons of activity. The median SULmax in the malignant lesions will be used for this analysis.
dispersion Type
Full Range
groups
  1. description
    Participants who received MSG dissolved in juice, in a fasting state, prior to the administration of 18F-DCFPyL, in either the first or second PET/CT scan.
    id
    OG000
    title
    18F-DCFPyL PET/CT Scan With MSG Drink
  2. description
    Participants who received the Placebo juice, in a fasting state, prior to the administration of 18F-DCFPyL, in either the first or second PET/CT scan.
    id
    OG001
    title
    18F-DCFPyL PET/CT Scan With Placebo Drink
param Type
MEDIAN
population Description
All participants who received at least one dose of each intervention and completed all study visits were included in the efficacy analysis.
reporting Status
POSTED
time Frame
scan with MSG and 3-7 days later, scan with Placebo (or vice versa)
title
Tumour Maximal Standardized Uptake Values Corrected for Lean Body Mass (SULmax) for 18F-DCFPyL
type
SECONDARY
type Units Analyzed
malignant lesions
unit Of Measure
SULmax

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice